NRC Quote, Financials, Valuation and Earnings

DarioHealth Corp. has a net margin of 5.11% compared to National Research Corp.'s net margin of -41.48%. National Research Corp.'s return on equity of 51.49% beat DarioHealth Corp.'s return on equity of -41.55%.

National Research Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand DarioHealth Corp. has an analysts' consensus of $18.00 which suggests that it could grow by 59.65%. Given that DarioHealth Corp. has higher upside potential than National Research Corp., analysts believe DarioHealth Corp. is more attractive than National Research Corp..

National Research Corp. has a beta of 0.490, which suggesting that the stock is 50.981% less volatile than S&P 500. In comparison DarioHealth Corp. has a beta of 1.161, suggesting its more volatile than the S&P 500 by 16.051%.

National Research Corp. has a quarterly dividend of $0.16 per share corresponding to a yield of 3.8%. DarioHealth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National Research Corp. pays 100.39% of its earnings as a dividend. DarioHealth Corp. pays out -- of its earnings as a dividend.

National Research Corp. quarterly revenues are $35.2M, which are larger than DarioHealth Corp. quarterly revenues of $5M. National Research Corp.'s net income of $1.8M is higher than DarioHealth Corp.'s net income of -$2.1M. Notably, National Research Corp.'s price-to-earnings ratio is 26.99x while DarioHealth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Research Corp. is 2.23x versus 6.26x for DarioHealth Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Mitesco, Inc. has a net margin of 5.11% compared to National Research Corp.'s net margin of -106766.67%. National Research Corp.'s return on equity of 51.49% beat Mitesco, Inc.'s return on equity of --.

National Research Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Mitesco, Inc. has an analysts' consensus of -- which suggests that it could grow by 305.16%. Given that Mitesco, Inc. has higher upside potential than National Research Corp., analysts believe Mitesco, Inc. is more attractive than National Research Corp..

National Research Corp. has a beta of 0.490, which suggesting that the stock is 50.981% less volatile than S&P 500. In comparison Mitesco, Inc. has a beta of 5.563, suggesting its more volatile than the S&P 500 by 456.284%.

National Research Corp. has a quarterly dividend of $0.16 per share corresponding to a yield of 3.8%. Mitesco, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National Research Corp. pays 100.39% of its earnings as a dividend. Mitesco, Inc. pays out -- of its earnings as a dividend.

National Research Corp. quarterly revenues are $35.2M, which are larger than Mitesco, Inc. quarterly revenues of $3K. National Research Corp.'s net income of $1.8M is higher than Mitesco, Inc.'s net income of -$3.2M. Notably, National Research Corp.'s price-to-earnings ratio is 26.99x while Mitesco, Inc.'s PE ratio is 2.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Research Corp. is 2.23x versus 24.83x for Mitesco, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Spok Holdings, Inc. has a net margin of 5.11% compared to National Research Corp.'s net margin of 9.46%. National Research Corp.'s return on equity of 51.49% beat Spok Holdings, Inc.'s return on equity of 10.88%.

National Research Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 54.87%. Given that Spok Holdings, Inc. has higher upside potential than National Research Corp., analysts believe Spok Holdings, Inc. is more attractive than National Research Corp..

National Research Corp. has a beta of 0.490, which suggesting that the stock is 50.981% less volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.415, suggesting its less volatile than the S&P 500 by 58.512%.

National Research Corp. has a quarterly dividend of $0.16 per share corresponding to a yield of 3.8%. Spok Holdings, Inc. offers a yield of 9.22% to investors and pays a quarterly dividend of $0.31 per share. National Research Corp. pays 100.39% of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

National Research Corp. quarterly revenues are $35.2M, which are larger than Spok Holdings, Inc. quarterly revenues of $33.9M. National Research Corp.'s net income of $1.8M is lower than Spok Holdings, Inc.'s net income of $3.2M. Notably, National Research Corp.'s price-to-earnings ratio is 26.99x while Spok Holdings, Inc.'s PE ratio is 16.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Research Corp. is 2.23x versus 2.01x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Vaso Corp. has a net margin of 5.11% compared to National Research Corp.'s net margin of 7.55%. National Research Corp.'s return on equity of 51.49% beat Vaso Corp.'s return on equity of 9.61%.

National Research Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Vaso Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that National Research Corp. has higher upside potential than Vaso Corp., analysts believe National Research Corp. is more attractive than Vaso Corp..

National Research Corp. has a beta of 0.490, which suggesting that the stock is 50.981% less volatile than S&P 500. In comparison Vaso Corp. has a beta of 0.466, suggesting its less volatile than the S&P 500 by 53.413%.

National Research Corp. has a quarterly dividend of $0.16 per share corresponding to a yield of 3.8%. Vaso Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National Research Corp. pays 100.39% of its earnings as a dividend. Vaso Corp. pays out -- of its earnings as a dividend.

National Research Corp. quarterly revenues are $35.2M, which are larger than Vaso Corp. quarterly revenues of $22.7M. National Research Corp.'s net income of $1.8M is higher than Vaso Corp.'s net income of $1.7M. Notably, National Research Corp.'s price-to-earnings ratio is 26.99x while Vaso Corp.'s PE ratio is 11.90x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Research Corp. is 2.23x versus 0.35x for Vaso Corp.. Usually stocks with elevated PS ratios are considered overvalued.